UniProt ID | S39A7_HUMAN | |
---|---|---|
UniProt AC | Q92504 | |
Protein Name | Zinc transporter SLC39A7 | |
Gene Name | SLC39A7 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 469 | |
Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein. Golgi apparatus, cis-Golgi network membrane. |
|
Protein Description | Zinc transporter, that transports Zn(2+) from the endoplasmic reticulum/Golgi apparatus to the cytosol. Transport is stimulated by growth factors, such as EGF, and Ca(2+), as well as by exogenous Zn(2+).. | |
Protein Sequence | MARGLGAPHWVAVGLLTWATLGLLVAGLGGHDDLHDDLQEDFHGHSHRHSHEDFHHGHSHAHGHGHTHESIWHGHTHDHDHGHSHEDLHHGHSHGYSHESLYHRGHGHDHEHSHGGYGESGAPGIKQDLDAVTLWAYALGATVLISAAPFFVLFLIPVESNSPRHRSLLQILLSFASGGLLGDAFLHLIPHALEPHSHHTLEQPGHGHSHSGQGPILSVGLWVLSGIVAFLVVEKFVRHVKGGHGHSHGHGHAHSHTRGSHGHGRQERSTKEKQSSEEEEKETRGVQKRRGGSTVPKDGPVRPQNAEEEKRGLDLRVSGYLNLAADLAHNFTDGLAIGASFRGGRGLGILTTMTVLLHEVPHEVGDFAILVQSGCSKKQAMRLQLLTAVGALAGTACALLTEGGAVGSEIAGGAGPGWVLPFTAGGFIYVATVSVLPELLREASPLQSLLEVLGLLGGVIMMVLIAHLE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
133 | Phosphorylation | KQDLDAVTLWAYALG CCCHHHHHHHHHHHH | 20.50 | 24043423 | |
137 | Phosphorylation | DAVTLWAYALGATVL HHHHHHHHHHHHHHH | 7.26 | 24043423 | |
142 | Phosphorylation | WAYALGATVLISAAP HHHHHHHHHHHHHCC | 17.66 | 24043423 | |
146 | Phosphorylation | LGATVLISAAPFFVL HHHHHHHHHCCEEEE | 17.76 | 24043423 | |
160 | Phosphorylation | LFLIPVESNSPRHRS EEEEECCCCCHHHHH | 42.73 | 24043423 | |
162 | Phosphorylation | LIPVESNSPRHRSLL EEECCCCCHHHHHHH | 32.37 | 24043423 | |
260 | Phosphorylation | AHSHTRGSHGHGRQE CCCCCCCCCCCCHHC | 24.01 | 26329039 | |
275 | Phosphorylation | RSTKEKQSSEEEEKE CCCCCCCCCHHHHHH | 51.27 | 29255136 | |
276 | Phosphorylation | STKEKQSSEEEEKET CCCCCCCCHHHHHHH | 46.67 | 29255136 | |
283 | Phosphorylation | SEEEEKETRGVQKRR CHHHHHHHHCCHHHC | 43.73 | 29255136 | |
293 | Phosphorylation | VQKRRGGSTVPKDGP CHHHCCCCCCCCCCC | 29.11 | 20068231 | |
294 | Phosphorylation | QKRRGGSTVPKDGPV HHHCCCCCCCCCCCC | 44.07 | 20068231 | |
297 | Ubiquitination | RGGSTVPKDGPVRPQ CCCCCCCCCCCCCCC | 71.61 | - | |
310 | Acetylation | PQNAEEEKRGLDLRV CCCHHHHHCCCCCHH | 55.86 | 26051181 | |
310 | Ubiquitination | PQNAEEEKRGLDLRV CCCHHHHHCCCCCHH | 55.86 | 21906983 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
275 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
276 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of S39A7_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of S39A7_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TYY1_HUMAN | YY1 | physical | 21988832 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275 AND SER-276, ANDMASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275 AND SER-276, ANDMASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275, AND MASSSPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275 AND SER-276, ANDMASS SPECTROMETRY. |